research
PHC9 COST-EFFECTIVENESS OF RIVAROXABANVERSUS ENOXAPARIN FORTHROMBOPROPHYLAXIS AFTER TOTAL HIP REPLACEMENT IN THE UK
- Publication date
- 30 November 2008
- Publisher
- International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.